Prestige Consumer Healthcare Inc. (PBH)

64,70 +0,05 (+0,08%) Börsenschluss: 04:00PM EDT

Prestige Consumer Healthcare Inc.

660 White Plains Road
Suite 250
Tarrytown, NY 10591
United States
914 524 6800
https://www.prestigebrands.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 570

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Ronald M. Lombardi	Chairman, President & CEO	1,98M	1,13M	1964
Ms. Christine Sacco	Chief Financial Officer	958,91k	N/A	1976
Mr. Jeffrey Zerillo	Senior Vice President of Operations	496,91k	N/A	1961
Mr. William C. P'Pool	Senior VP, General Counsel & Corporate Secretary	769,98k	919,7k	1965
Mr. Adel Mekhail	Executive Vice President of Marketing & Sales	797,94k	N/A	1961
Mr. Philip David Terpolilli	Director of Investor Relations	N/A	N/A	N/A
Dean Siegal	Director of Communications	N/A	N/A	N/A
Ms. Mary Beth Fritz	Senior Vice President of Quality & Regulatory Affairs	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Corporate Governance

Prestige Consumer Healthcare Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 4. Die grundlegenden Scores sind Audit: 6, Vorstand: 3, Shareholderrechte: 5, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.